Boiron SA (BON) AI Stock Analysis

Boiron SA

(Frankfurt:BON)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low LeverageVery low leverage gives Boiron substantial financial flexibility and reduces the burden of interest and refinancing costs. This conservative capital structure can help the company withstand operating volatility while preserving capacity to invest, maintain products, or return cash to shareholders.

Negative Factors

Severe Revenue ContractionThe severe reported 2025 revenue contraction and broader history of uneven declines weaken visibility into Boiron’s underlying demand. Persistent top-line instability can limit operating leverage, complicate planning, and make future earnings less dependable even when profitability improves.

Boiron SA (BON) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 323.81M
Dividend Yield: 7.32%
Average Volume (3M): 120
Price to Earnings (P/E): 12.6
Beta (1Y): -0.07
Revenue Growth: -1.80%
EPS Growth: 35.22%
Country: Germany
Employees: 2,623
Sector: General
Sector Strength: 55
Industry: Drug Manufacturers - Specialty & Generic

Boiron SA Business Overview & Revenue Model

Company Description

Boiron S.A. is a global pharmaceutical company specializing in the production and distribution of homeopathic remedies across France, Europe, North America, and other international markets. Its extensive product portfolio encompasses a range of non-p...

Boiron SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

DE:BON against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:IPN	71Outperform	EUR 13.04B	25.42	11.33%	1.02%	13.63%	14.45%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
FR:VLA	44Neutral	EUR 466.70M	-2.73	-152.15%	―	-27.19%	-117.39%
FR:DBV	40Underperform	EUR 534.36M	-3.17	-121.83%	―	―	45.11%
FR:AB	39Underperform	EUR 52.22M	-6.72	27.28%	―	12.66%	44.01%

* General Sector Average

Performance Comparison

DE:BON and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:BON	Boiron SA	18.30	-8.24	-31.05%
FR:DBV	Dbv Technologies SA (UK)	1.70	-0.77	-31.17%
FR:IPN	Ipsen	157.60	36.39	30.02%
FR:ALCOX	Nicox SA	0.30	-0.04	-12.06%
FR:VLA	Valneva (0OB3)	2.45	-1.44	-37.04%
FR:AB	Ab Science	0.54	-0.64	-54.31%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Boiron SA AI Stock Analysis